266 related articles for article (PubMed ID: 10695690)
21. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
[TBL] [Abstract][Full Text] [Related]
22. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
[TBL] [Abstract][Full Text] [Related]
23. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
[TBL] [Abstract][Full Text] [Related]
24. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s.
Maschmeyer G; Braveny I
Eur J Clin Microbiol Infect Dis; 2000 Dec; 19(12):915-25. PubMed ID: 11205628
[TBL] [Abstract][Full Text] [Related]
25. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
26. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan.
Lai HP; Hsueh PR; Chen YC; Lee PI; Lu CY; Lu MY; Lin WC; Hsieh YC; Lee CY; Lin KH; Huang LM
J Microbiol Immunol Infect; 2003 Sep; 36(3):197-202. PubMed ID: 14582565
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital.
Kuikka A; Valtonen VV
Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):701-8. PubMed ID: 9865983
[TBL] [Abstract][Full Text] [Related]
28. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
[TBL] [Abstract][Full Text] [Related]
29. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with
Albasanz-Puig A; Gudiol C; Parody R; Tebe C; Akova M; Araos R; Bote A; Brunel AS; Calik S; Drgona L; García E; Hemmati P; Herrera F; Ibrahim KY; Isler B; Kanj S; Kern W; Maestro de la Calle G; Manzur A; Marin JI; Márquez-Gómez I; Martín-Dávila P; Mikulska M; Montejo JM; Montero M; Morales HMP; Morales I; Novo A; Oltolini C; Peghin M; Del Pozo JL; Puerta-Alcalde P; Ruiz-Camps I; Sipahi OR; Tilley R; Yáñez L; Gomes MZR; Carratalà J;
BMJ Open; 2019 May; 9(5):e025744. PubMed ID: 31129580
[TBL] [Abstract][Full Text] [Related]
30. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
Furuichi M; Ito K; Miyairi I
Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
Tschudin-Sutter S; Fosse N; Frei R; Widmer AF
PLoS One; 2018; 13(9):e0203295. PubMed ID: 30235247
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with ceftazidime/avibactam for treatment of antibiotic-resistant organisms other than Klebsiella pneumoniae.
Santevecchi BA; Smith TT; MacVane SH
Int J Antimicrob Agents; 2018 Apr; 51(4):629-635. PubMed ID: 29408227
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa.
Horino T; Chiba A; Kawano S; Kato T; Sato F; Maruyama Y; Nakazawa Y; Yoshikawa K; Yoshida M; Hori S
Intern Med; 2012; 51(1):59-64. PubMed ID: 22214624
[TBL] [Abstract][Full Text] [Related]
35. Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome.
Fergie JE; Shema SJ; Lott L; Crawford R; Patrick CC
Clin Infect Dis; 1994 Mar; 18(3):390-4. PubMed ID: 8011821
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
Geletko SM; Melbourne KM; Mikolich DJ
Ann Pharmacother; 1996 Mar; 30(3):246-8. PubMed ID: 8833559
[TBL] [Abstract][Full Text] [Related]
37. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
38. Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.
Bliziotis IA; Petrosillo N; Michalopoulos A; Samonis G; Falagas ME
PLoS One; 2011; 6(10):e26470. PubMed ID: 22046290
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for the failure of treatment of
Yoshida S; Suzuki K; Suzuki A; Okada H; Niwa T; Kobayashi R; Murakami N; Ogura S; Itoh Y
Pharmazie; 2017 Jul; 72(7):428-432. PubMed ID: 29441942
[TBL] [Abstract][Full Text] [Related]
40. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
